Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Praxis Precision Medicines Inc (PRAX)

Praxis Precision Medicines Inc (PRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Praxis Precision Medicines Inc 99 HIGH STREET 30TH FLOOR BOSTON MA 02110 USA

www.praxismedicines.com Employees: 82 P: 617-300-8460

Description:

Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,276,195
Enterprise Value, $K 1,194,895
Shares Outstanding, K 17,757
Annual Sales, $ 2,450 K
Annual Net Income, $ -123,280 K
Last Quarter Sales, $ 360 K
Last Quarter Net Income, $ -32,680 K
EBIT, $ -132,710 K
EBITDA, $ -132,230 K
60-Month Beta 2.67
% of Insider Shareholders 2.70%
% of Institutional Shareholders 67.84%
Float, K 17,278
% Float 97.30%
Short Volume Ratio 0.23

Growth:

1-Year Return 378.41%
3-Year Return -76.42%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.74 on 08/13/24
Next Earnings Date 11/06/24 [BMO]
Earnings Per Share ttm -10.25
EPS Growth vs. Prev Qtr 38.73%
EPS Growth vs. Prev Year 76.31%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 11/29/23

PRAX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.47%
Return-on-Assets % -55.86%
Profit Margin % -5,031.84%
Debt/Equity 0.00
Price/Sales 527.78
Price/Cash Flow N/A
Price/Book 2.97
Book Value/Share 24.49
Interest Coverage -1.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar